
Let's Talk Lymphoedema
Format: Paperback
ISBN13: 9781783962853
Paperback|9781783962853
✨ Featured Offer
Used, Very Good
$17.08
List Price: $23.95
🚚
See all 2 offers from $17.08 FREE standard delivery by: 30 Mar 2026
Overview
Lymphoedema results from a failure of the lymphatic system, causing swelling and fluid retention; it can also cause aching, heaviness and difficulty moving. Research shows that around 140 million people worldwide may be living with lymphoedema, and it affects approximately one in five women after breast cancer treatment. There is no cure for the disease, but there are ways to control the symptoms.
Let's Talk Lymphoedema has been written to help sufferers deal with its debilitating effects, providing information and inspiration to help them lead rich, vibrant lives. It features contributions from international experts and personalities such as Miriam Stoppard, and the actress Kathy Bates, who herself suffers from the condition.
Including essential medical information (immune system and infection; microsurgery; obesity; podiatry); treatment advice (compression garments; physiotherapy; exercises); and day-to-day support (psychology, sexuality and others' perceptions), this is an essential read for sufferers, friends, family and medical professionals alike.
| ISBN-13 | 9781783962853 |
|---|---|
| ISBN-10 | 1783962852 |
| Weight | 1.30 Pounds |
| Dimensions | 6.00 x 0.70 x 9.25 In |
| List Price | $23.95 |
| Edition | 1st Edition |
| Format | Paperback |
|---|---|
| Language | English |
| Pages | 210 pages |
| Publisher | Elliott & Thompson |
| Published On | 2017-06-01 |
View All Offers
Sort by:
Price
Condition
Seller
Seller Comments
Price
✨ Used, Very Good
Seller details
HPB-Diamond
Dallas, TX, USA
Connecting readers with great books since 1972! Used books may not include companion materials, and ...
Free delivery by: 30 Mar 2026
Used, Good
Seller details
Bonita
Santa Clarita, CA, USA
Access codes and supplements are not guaranteed with used items. May be an ex-library book.
Free delivery by: 30 Mar 2026